Oslo University Hospital / Oslo Universitetssykehus Rikshospitalet

Hospital


Location: Oslo, Norway (NO) NO

ISNI: 0000000403898485

ROR: https://ror.org/00j9c2840

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Common variants in breast cancer risk loci predispose to distinct tumor subtypes (2022) Ahearn TU, Zhang H, Michailidou K, Milne RL, Bolla MK, Dennis J, Dunning AM, et al. Journal article Stratification in systemic sclerosis according to autoantibody status versus skin involvement: a study of the prospective EUSTAR cohort. (2022) Elhai M, Sritharan N, Boubaya M, Balbir-Gurman A, Siegert E, Hachulla E, de Vries-Bouwstra J, et al. Journal article NT-proBNP and stem cell factor plasma concentrations are independently associated with cardiovascular outcomes in end-stage renal disease hemodialysis patients. (2022) Rossignol P, Duarte K, Bresso E, Åsberg A, Devignes MD, Eriksson N, Girerd N, et al. Journal article CODE-EHR best-practice framework for the use of structured electronic health-care records in clinical research. (2022) Kotecha D, Asselbergs FW, Achenbach S, Anker SD, Atar D, Baigent C, Banerjee A, et al. Journal article, Review article Corrigendum to ‘Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up’: (Annals of Oncology (2021) 32(3) (309–322), (S0923753420431692), (10.1016/j.annonc.2020.11.014)) (2022) Dimopoulos MA, Moreau P, Terpos E, Mateos MV, Zweegman S, Cook G, Delforge M, et al. Journal article, Erratum Phenotype of limited cutaneous systemic sclerosis patients with positive anti-topoisomerase I antibodies: data from the EUSTAR cohort. (2022) Zanatta E, Huscher D, Ortolan A, Avouac J, Airo P, Balbir-Gurman A, Siegert E, et al. Journal article Treatment Characteristics and Real-World Progression-Free Survival in Patients With Unresectable Stage III NSCLC Who Received Durvalumab After Chemoradiotherapy: Findings From the PACIFIC-R Study (2022) Girard N, Bar J, Garrido P, Garassino MC, McDonald F, Mornex F, Filippi AR, et al. Journal article Motorized spiral enteroscopy: Results of an international multicenter prospective observational clinical study in patients with normal and altered gastrointestinal anatomy (2022) Beyna T, Moreels T, Arvanitakis M, Pioche M, Saurin JC, May A, Knabe M, et al. Journal article Estimated glomerular filtration rate is a marker of mortality in the European Scleroderma Trials and Research Group (EUSTAR) database (2022) Gigante A, Hoffmann-Vold AM, Fegatelli DA, Gabrielli A, Leodori G, Coleiro B, De Santis M, et al. Journal article Evidenzbasierte Off-label-Anwendung von Arzneimitteln bei Kindern und Jugendlichen (2022) Male C, Neubert A, Grytli H, Gradwohl C, Strommer B, Lagler FB, Rascher W, et al. Journal article, Review article